Lv1
40 积分 2023-07-09 加入
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
24天前
已完结
CHI3L3+ immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases
1个月前
已完结
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
2个月前
已完结
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
2个月前
已完结
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC
3个月前
已完结
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC
3个月前
已完结
Linking tumour angiogenesis and tumour immunity
7个月前
已完结
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
1年前
已完结
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
1年前
已完结
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
1年前
已完结
皖公网安备34019202002308
